Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Synthon Pharms Drug Patent Portfolio

Synthon Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Synthon Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6828339 Amlodipine salt forms and processes for preparing them 20 Nov, 2022 Expired


Given below is the list of recent legal activities going on the following drug patents of Synthon Pharms.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
07 Jan, 2013 US6828339
Change in Power of Attorney (May Include Associate POA)
Critical
16 Apr, 2007 US6828339
Correspondence Address Change
Critical
16 Apr, 2007 US6828339
Correspondence Address Change
Critical
09 Mar, 2005 US6828339
Recordation of Patent Grant Mailed
Critical
07 Dec, 2004 US6828339
Patent Issue Date Used in PTA Calculation
Critical
07 Dec, 2004 US6828339
Issue Notification Mailed
Critical
18 Nov, 2004 US6828339
Receipt into Pubs 15 Nov, 2004 US6828339
Dispatch to FDC 11 Nov, 2004 US6828339
Receipt into Pubs 05 Nov, 2004 US6828339
Application Is Considered Ready for Issue
Critical
29 Oct, 2004 US6828339
Miscellaneous Communication to Applicant - No Action Count 06 Oct, 2004 US6828339
Mail Miscellaneous Communication to Applicant 06 Oct, 2004 US6828339
Issue Fee Payment Received
Critical
02 Jul, 2004 US6828339
Issue Fee Payment Verified
Critical
02 Jul, 2004 US6828339


Synthon Pharms's Family Patents

Synthon Pharms drugs have patent protection in a total of 6 countries. It's US patent count contributes only to 37.5% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Synthon Pharms Drug List

Given below is the complete list of Synthon Pharms's drugs and the patents protecting them.


1. Amlodipine Besylate

Amlodipine Besylate is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6828339 Amlodipine salt forms and processes for preparing them 20 Nov, 2022
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Amlodipine Besylate's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List